Cited by 376Alzheimer's disease research and treatmentsDementia and Cognitive Impairment ResearchGenetic Associations and Epidemiology

The DOI matches its Crossref record; 69 of the 71 references it cites were found in a registry or an index.

Hippocampal Atrophy as a Quantitative Trait in a Genome-Wide Association Study Identifying Novel Susceptibility Genes for Alzheimer's Disease

Open access

Potkin, Steven G., Guffanti, Guia, Lakatos, Anita, Turner, Jessica A., Kruggel, Frithjof, Fallon, James H., Saykin, Andrew J., Orro, Alessandro, Lupoli, Sara, Salvi, Erika, Weiner, Michael, Macciardi, Fabio, for the Alzheimer's Disease Neuroimaging Initiative·2009·PLoS ONE

DOI 10.1371/journal.pone.0006501PMC PMC2719581

Open this paper in CoChat — free account Open PDF

Abstract

BACKGROUND: With the exception of APOE epsilon4 allele, the common genetic risk factors for sporadic Alzheimer's Disease (AD) are unknown. METHODS AND FINDINGS: We completed a genome-wide association study on 381 participants in the ADNI (Alzheimer's Disease Neuroimaging Initiative) study. Samples were genotyped using the Illumina Human610-Quad BeadChip. 516,645 unique Single Nucleotide Polymorphisms (SNPs) were included in the analysis following quality control measures. The genotype data and raw genetic data are freely available for download (LONI, http://www.loni.ucla.edu/ADNI/Data/). Two analyses were completed: a standard case-control analysis, and a novel approach using hippocampal atrophy measured on MRI as an objectively defined, quantitative phenotype. A General Linear Model was applied to identify SNPs for which there was an interaction between the genotype and diagnosis on the quantitative trait. The case-control analysis identified APOE and a new risk gene, TOMM40 (translocase of outer mitochondrial membrane 40), at a genome-wide significance level of < or =10(-6) (10(-11) for a haplotype). TOMM40 risk alleles were approximately twice as frequent in AD subjects as controls. The quantitative trait analysis identified 21 genes or chromosomal areas with at least one SNP with a p-value < or =10(-6), which can be considered potential "new" candidate loci to explore in the etiology of sporadic AD. These candidates included EFNA5, CAND1, MAGI2, ARSB, and PRUNE2, genes involved in the regulation of protein degradation, apoptosis, neuronal loss and neurodevelopment. Thus, we identified common genetic variants associated with the increased risk of developing AD in the ADNI cohort, and present publicly available genome-wide data. Supportive evidence based on case-control studies and biological plausibility by gene annotation is provided. Currently no available sample with both imaging and genetic data is available for replication. CONCLUSIONS: Using hippocampal atrophy as a quantitative phenotype in a genome-wide scan, we have identified candidate risk genes for sporadic Alzheimer's disease that merit further investigation.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0006501

Cites

69 of 69 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Clinical diagnosis of Alzheimer's disease: Report of the NINCDS‐ADRDA Work Group* under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single subject brain
Tzourio-Mazoyer, N., Landeau, B., Papathanassiou, D., Crivello, F., Etard, O., Delcroix, N., Mazoyer, B., & Joliot, M. (2002) · NeuroImage · doi:10.1006/nimg.2001.0978 · Cited by 16,319
Haploview: analysis and visualization of LD and haplotype maps
Barrett, J. C., Fry, B., Maller, J., & Daly, M. J. (2004) · Bioinformatics · doi:10.1093/bioinformatics/bth457 · Cited by 14,551
Advances in functional and structural MR image analysis and implementation as FSL
Smith, S. M., Jenkinson, M., Woolrich, M. W., Beckmann, C. F., Behrens, T. E. J., Johansen-Berg, H., Bannister, P. R., De Luca, M., Drobnjak, I., Flitney, D. E., et al. (2004) · NeuroImage · doi:10.1016/j.neuroimage.2004.07.051 · Cited by 13,630
Principal components analysis corrects for stratification in genome-wide association studies
Price, A. L., Patterson, N. J., Plenge, R. M., Weinblatt, M. E., Shadick, N. A., & Reich, D. (2006) · Nature Genetics · doi:10.1038/ng1847 · Cited by 10,248
Voxel-Based Morphometry—The Methods
Ashburner, J., & Friston, K. J. (2000) · NeuroImage · doi:10.1006/nimg.2000.0582 · Cited by 8,676
A second generation human haplotype map of over 3.1 million SNPs
The International HapMap Consortium (2007) · Nature · doi:10.1038/nature06258 · Cited by 4,438
Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS–ADRDA criteria
Dubois, B., Feldman, H. H., Jacova, C., DeKosky, S. T., Barberger-Gateau, P., Cummings, J., Delacourte, A., Galasko, D., Gauthier, S., Jicha, G., et al. (2007) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70178-3 · Cited by 4,411
The Alzheimer’s disease neuroimaging initiative (ADNI): MRI methods
Jack, C. R., Bernstein, M. A., Fox, N. C., Thompson, P., Alexander, G., Harvey, D., Borowski, B., Britson, P. J., L. Whitwell, J., Ward, C., et al. (2008) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.21049 · Cited by 4,347
Genome-wide association studies for common diseases and complex traits
Hirschhorn, J. N., & Daly, M. J. (2005) · Nature Reviews Genetics · doi:10.1038/nrg1521 · Cited by 2,923

Flagged first, then by citations

Show all 71 references

2 of the 71 references couldn’t be matched to a known paper.

Sorted by citations

Items 101–200 of 371

Genomic Copy Number Analysis in Alzheimer′s Disease and Mild Cognitive Impairment: An ADNI Study
Swaminathan, S., Kim, S., Shen, L., Risacher, S. L., Foroud, T., Pankratz, N., Potkin, S. G., Huentelman, M. J., Craig, D. W., Weiner, M. W., et al. (2011) · International Journal of Alzheimer s Disease · doi:10.4061/2011/729478 · Cited by 66
Multiple loci influencing hippocampal degeneration identified by genome scan
Melville, S. A., Buros, J. L., Parrado, A., Vardarajan, B. N., Logue, M. W., Shen, L., Risacher, S. L., Kim, S., Jun, G., DeCarli, C. S., et al. (2012) · Annals of Neurology · doi:10.1002/ana.23644 · Cited by 67
The expanding family of FERM proteins
Moleirinho, S., Tilston-Lünel, A., Angus, L., Gunn‐Moore, F. J., & Reynolds, P. A. (2013) · Biochemical Journal · doi:10.1042/bj20121642 · Cited by 68
A review on omics-based biomarkers discovery for Alzheimer's disease from the bioinformatics perspectives: Statistical approach vs machine learning approach
Tan, M. S., Cheah, P., Chin, A., Looi, L., & Chang, S. (2021) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2021.104947 · Cited by 66
A Machine Learning Approach to Predicting Autism Risk Genes: Validation of Known Genes and Discovery of New Candidates
Lin, Y., Afshar, S., Rajadhyaksha, A. M., Potash, J. B., & Han, S. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2020.500064 · Cited by 61
Neuroimaging Measures as Endophenotypes in Alzheimer′s Disease
Braskie, M. N., Ringman, J. M., & Thompson, P. M. (2011) · International Journal of Alzheimer s Disease · doi:10.4061/2011/490140 · Cited by 62
Investigation of 15 of the top candidate genes for late-onset Alzheimer’s disease
Belbin, O., Carrasquillo, M. M., Crump, M., Culley, O. J., Hunter, T. A., Ma, L., Bisceglio, G. D., Zou, F., Allen, M., Dickson, D. W., et al. (2010) · Human Genetics · doi:10.1007/s00439-010-0924-2 · Cited by 60
Nonlinear cerebral atrophy patterns across the Alzheimer's disease continuum: impact of APOE4 genotype
Gispert, J. D., Rami, L., Sánchez‐Benavides, G., Falcón, C., Tucholka, A., Rojas, S., & Molinuevo, J. L. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2015.06.027 · Cited by 56
Clinical Genetics of Alzheimer’s Disease
Zou, Z., Liu, C., Che, C., & Huang, H. (2014) · BioMed Research International · doi:10.1155/2014/291862 · Cited by 60
Genomic Approaches to Posttraumatic Stress Disorder: The Psychiatric Genomic Consortium Initiative
Nievergelt, C. M., Ashley‐Koch, A. E., Dalvie, S., Hauser, M. A., Morey, R. A., Smith, A. K., & Uddin, M. (2018) · Biological Psychiatry · doi:10.1016/j.biopsych.2018.01.020 · Cited by 60
Multilocus Genetic Analysis of Brain Images
Hibar, D. P., Omid Kohannim, A., Stein, J. L., Chiang, M., & Thompson, P. M. (2011) · Frontiers in Genetics · doi:10.3389/fgene.2011.00073 · Cited by 55
Seeking Optimal Region-Of-Interest (ROI) Single-Value Summary Measures for fMRI Studies in Imaging Genetics
Tong, Y., Chen, Q., Nichols, T. E., Rasetti, R., Callicott, J. H., Berman, K. F., Weinberger, D. R., & Mattay, V. S. (2016) · PLoS ONE · doi:10.1371/journal.pone.0151391 · Cited by 55
Developmental MRI markers cosegregate juvenile patients with myoclonic epilepsy and their healthy siblings
Wandschneider, B., Hong, S., Bernhardt, B. C., Fadaie, F., Vollmar, C., Koepp, M. J., Bernasconi, N., & Bernasconi, A. (2019) · Neurology · doi:10.1212/wnl.0000000000008173 · Cited by 53
Towards a reference genome that captures global genetic diversity
Wong, K. H. Y., Ma, W., Wei, C.-Y., Yeh, E., Lin, W.-J., Wang, E. H. F., Su, J.-P., Hsieh, F., Kao, H., Chen, H., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-19311-w · Cited by 55
Amyloid pathway-based candidate gene analysis of [11C]PiB-PET in the Alzheimer’s Disease Neuroimaging Initiative (ADNI) cohort
Swaminathan, S., Shen, L., Risacher, S. L., Yoder, K. K., West, J. D., Kim, S., Nho, K. T., Foroud, T., Inlow, M. H., Potkin, S. G., et al. (2011) · Brain Imaging and Behavior · doi:10.1007/s11682-011-9136-1 · Cited by 54
Genetics and Brain Morphology
Strike, L. T., Couvy‐Duchesne, B., Hansell, N. K., Cuéllar-Partida, G., Medland, S. E., & Wright, M. J. (2015) · Neuropsychology Review · doi:10.1007/s11065-015-9281-1 · Cited by 53
Influence of Genetic Variation on Plasma Protein Levels in Older Adults Using a Multi-Analyte Panel
Kim, S., Swaminathan, S., Inlow, M. H., Risacher, S. L., Nho, K. T., Shen, L., Foroud, T., Petersen, R. C., Aisen, P. S. S., Soares, H. D., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0070269 · Cited by 55
A Longitudinal Imaging Genetics Study of Neuroanatomical Asymmetry in Alzheimer’s Disease
Wachinger, C., Nho, K. T., Saykin, A. J., Reuter, M., & Rieckmann, A. (2018) · Biological Psychiatry · doi:10.1016/j.biopsych.2018.04.017 · Cited by 53
Relationship Between CSF Biomarkers of Alzheimer's Disease and Rates of Regional Cortical Thinning in ADNI Data
Tosun, D., Initiative1, T. A. D. N., Schuff, N. W., Shaw, L. M. J., Trojanowski, J. Q., & Weiner, M. W. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-0006 · Cited by 51
Dysregulated Fc gamma receptor–mediated phagocytosis pathway in Alzheimer's disease: network-based gene expression analysis
Park, Y. H., Hodges, A., Risacher, S. L., Lin, K., Jang, J., Ahn, S., Kim, S., Lovestone, S., Simmons, A., Weiner, M. W., et al. (2019) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2019.12.001 · Cited by 53
Longitudinal analysis is more powerful than cross-sectional analysis in detecting genetic association with neuroimaging phenotypes
Xu, Z., Shen, X., Pan, W., & Initiative, F. T. A. D. N. (2014) · PLoS ONE · doi:10.1371/journal.pone.0102312 · Cited by 51
Susceptibility of brain atrophy to TRIB3 in Alzheimer’s disease, evidence from functional prioritization in imaging genetics
Lorenzi, M., Altmann, A., Gutman, B. A., Wray, S., Arber, C., Hibar, D. P., Jahanshad, N., Schott, J. M., Alexander, D. C., Thompson, P. M., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1706100115 · Cited by 52
Pharmacogenetic Considerations in the Treatment of Alzheimer’s Disease
Cacabelos, R., Torrellas, C., Teijido, Ó., & Carril, J. C. (2016) · Pharmacogenomics · doi:10.2217/pgs-2016-0031 · Cited by 50
Impact of APOE-ε4 carriage on the onset and rates of neocortical Aβ-amyloid deposition
Burnham, S. C., Laws, S. M., Budgeon, C. A., Doré, V., Porter, T., Bourgeat, P., Buckley, R. F., Murray, K., Ellis, K. A., Turlach, B. A., et al. (2020) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2020.06.001 · Cited by 55
Novel function of VEGF-B as an antioxidant and therapeutic implications
Chen, R., Lee, C., Lin, X., Zhao, C., & Li, X. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.03.002 · Cited by 51
Genetic interactions associated with 12-month atrophy in hippocampus and entorhinal cortex in Alzheimer's Disease Neuroimaging Initiative
Meda, S. A., Koran, M. E. I., Pryweller, J. R., Vega, J. N., & Thornton‐Wells, T. A. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.09.020 · Cited by 46
APOE-epsilon4 and aging of medial temporal lobe gray matter in healthy adults older than 50 years
Taylor, J. L., Scanlon, B. K., Farrell, M. E., Hernandez, B., Adamson, M. M., Ashford, J. W., Noda, A. M., Murphy, G. M., & Weiner, M. W. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.05.011 · Cited by 48
The influence of APOE and TOMM40 polymorphisms on hippocampal volume and episodic memory in old age
Ferencz, B., Laukka, E. J., Lövdén, M., Kalpouzos, G., Keller, L., Graff, C., Wahlund, L., Fratiglioni, L., & Bäckman, L. (2013) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2013.00198 · Cited by 45
The Heritability of Cortical Folding: Evidence from the Human Connectome Project
Schmitt, J. E., Raznahan, A., Liu, S., & Neale, M. C. (2020) · Cerebral Cortex · doi:10.1093/cercor/bhaa254 · Cited by 44
Somatic Signature of Brain-Specific Single Nucleotide Variations in Sporadic Alzheimer's Disease
Parcerisas, A., Rubio, S. E., Muhaisen, A., Gómez-Ramos, A., Pujadas, L., Puiggros, M., Rossi, D., Ureña, J., Burgaya, F., Pascual, M., et al. (2014) · Journal of Alzheimer’s Disease · doi:10.3233/jad-140891 · Cited by 44
Intermediate Phenotypes Identify Divergent Pathways to Alzheimer's Disease
Shulman, J. M., Chibnik, L. B., Aubin, C., Schneider, J. A., Bennett, D., & Jager, P. L. D. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011244 · Cited by 47
Structural Neuroimaging Genetics Interactions in Alzheimer’s Disease
Moon, S. W., Dinov, I. D., Kim, J., Zamanyan, A., Hobel, S., Thompson, P. M., Toga, A. W., & Initiative, A. F. T. A. D. N. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-150335 · Cited by 43
Genome‐wide mediation analysis of psychiatric and cognitive traits through imaging phenotypes
Bi, X., Yang, L., Li, T., Wang, B., Hongtu Zhu, B., & Zhang, H. (2017) · Human Brain Mapping · doi:10.1002/hbm.23650 · Cited by 41
Lack of an association of BDNF Val66Met polymorphism and plasma BDNF with hippocampal volume and memory
Initiative, A. D. N., Kim, A., Fagan, A. M., Goate, A., Benzinger, T. L. S., Morris, J. C., & Head, D. M. (2015) · Cognitive Affective & Behavioral Neuroscience · doi:10.3758/s13415-015-0343-x · Cited by 42
Implicating causal brain imaging endophenotypes in Alzheimer’s disease using multivariable IWAS and GWAS summary data
Knutson, K. A., Deng, Y., & Pan, W. (2020) · NeuroImage · doi:10.1016/j.neuroimage.2020.117347 · Cited by 41
Genome-wide association study identifies multiple novel loci associated with disease progression in subjects with mild cognitive impairment
Hu, X., Pickering, E. H., Hall, S. K., Naik, S. U., Liu, Y., Soares, H. D., Katz, E., Paciga, S. A., Liu, W., Aisen, P. S. S., et al. (2011) · Translational Psychiatry · doi:10.1038/tp.2011.50 · Cited by 40
A review of brain imaging biomarker genomics in Alzheimer’s disease: implementation and perspectives
Li, L., Yu, X., Sheng, C., Jiang, X., Zhang, Q., Han, Y., & Jiang, J. (2022) · Translational Neurodegeneration · doi:10.1186/s40035-022-00315-z · Cited by 40
Genome-wide association study identifies 5q21 and 9p24.1 (KDM4C) loci associated with alcohol withdrawal symptoms
Wang, K.-S., Liu, X., Zhang, Q., Wu, L.-Y., & Min De, Z. E. N. G. (2011) · Journal of Neural Transmission · doi:10.1007/s00702-011-0729-z · Cited by 40
Alzheimer’s Genetics in the GWAS Era: A Continuing Story of ‘Replications and Refutations’
Bertram, L. (2011) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-011-0193-z · Cited by 40
Genetic underpinnings of white matter ‘connectivity’: Heritability, risk, and heterogeneity in schizophrenia
Voineskos, A. N. (2014) · Schizophrenia Research · doi:10.1016/j.schres.2014.03.034 · Cited by 39
Alzheimer's disease risk genes and the age-at-onset phenotype
Thambisetty, M., An, Y., & Tanaka, T. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.05.028 · Cited by 43
Alzheimer’s Disease Susceptibility Genes APOE and TOMM40, and Hippocampal Volumes in the Lothian Birth Cohort 1936
Lyall, D. M., Royle, N. A., Harris, S. E., Bastin, M. E., Maniega, S. M., Murray, C. L., Lutz, M. W., Saunders, A. M., Roses, A. D., Hernández, M. C. D. V., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0080513 · Cited by 37
The TOMM40 gene rs2075650 polymorphism contributes to Alzheimer’s disease in Caucasian, and Asian populations
Huang, H., Zhao, J. Y., Xu, B., Ma, X., Dai, Q., Li, T., Xue, F., & Chen, B. (2016) · Neuroscience Letters · doi:10.1016/j.neulet.2016.05.050 · Cited by 37
The therapeutic implications of all-in-one AAV-delivered epigenome-editing platform in neurodegenerative disorders
Kantor, B., O’Donovan, B., Rittiner, J. E., Hodgson, D., Lindner, N., Guerrero, S., Dong, W., Zhang, A., & Chiba‐Falek, O. (2024) · Nature Communications · doi:10.1038/s41467-024-50515-6 · Cited by 48
Gene-based GWAS and biological pathway analysis of the resilience of executive functioning
Initiative, A. D. N., Mukherjee, S., Kim, S., Ramanan, V. K., Gibbons, L. E., Nho, K. T., Glymour, M. M., Ertekin‐Taner, N., Montine, T. J., Saykin, A. J., et al. (2013) · Brain Imaging and Behavior · doi:10.1007/s11682-013-9259-7 · Cited by 38
A Draft De Novo Genome Assembly for the Northern Bobwhite (Colinus virginianus) Reveals Evidence for a Rapid Decline in Effective Population Size Beginning in the Late Pleistocene
Halley, Y., Dowd, S. E., Decker, J. E., Seabury, P. M., Bhattarai, E. K., Johnson, C. D., Rollins, D., Tizard, I. R., Brightsmith, D. J., Peterson, M. J., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0090240 · Cited by 38
A Genome-Wide Association Study to Detect QTL for Commercially Important Traits in Swiss Large White Boars
Becker, D., Wimmers, K., Luther, H., Andreas Hofer, A., & Leeb, T. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055951 · Cited by 38
Alzheimer’s disease: diagnostics, prognostics and the road to prevention
Grossman, I., Lutz, M. W., Crenshaw, D. G., Saunders, A. M., Burns, D. K., & Roses, A. D. (2010) · EPMA Journal · doi:10.1007/s13167-010-0024-3 · Cited by 37
Loss of TANGO1 Leads to Absence of Bone Mineralization
Guillemyn, B., Nampoothiri, S., Syx, D., Malfait, F., & Symoens, S. (2020) · JBMR Plus · doi:10.1002/jbm4.10451 · Cited by 37
Genetics of Alzheimer's Disease
Bertram, L., & Tanzi, R. E. (2011) · Wiley eBooks · doi:10.1002/9781444341256.ch9 · Cited by 37
Genome-wide and gene-based association implicates FRMD6 in alzheimer disease
Hong, M., Reynolds, C. A., Feldman, A. L., Kallin, M., Lambert, J., Amouyel, P., Ingelsson, E., Pedersen, N. L., & Prince, J. A. (2011) · Human Mutation · doi:10.1002/humu.22009 · Cited by 35
Association of TOMM40 Polymorphisms with Late-Onset Alzheimer’s Disease in a Northern Han Chinese Population
Ma, X., Yu, J., Wang, W., Wang, H.-F., Liu, Q., Zhang, W., & Tan, L. (2013) · NeuroMolecular Medicine · doi:10.1007/s12017-012-8217-7 · Cited by 35
Role and treatment of mitochondrial DNA-related mitochondrial dysfunction in sporadic neurodegenerative diseases
H. Swerdlow, R. (2011) · Current Pharmaceutical Design · doi:10.2174/138161211798072535 · Cited by 35
Neuroplasticity and memory formation in major depressive disorder: An imaging genetics perspective on serotonin and BDNF
Kuhn, M., Weidenauer, A., & Pezawas, L. (2014) · Restorative Neurology and Neuroscience · doi:10.3233/rnn-139005 · Cited by 38
Roles of phosphoinositide-specific phospholipase Cγ1 in brain development
Kang, D., Yang, Y. R., Lee, C., Kim, S., Ryu, S. H., & Suh, P. (2015) · Advances in Biological Regulation · doi:10.1016/j.jbior.2015.10.002 · Cited by 38
Ikzf1 as a novel regulator of microglial homeostasis in inflammation and neurodegeneration
Ballasch, I., García-García, E., Vila, C., Pérez-González, A., Sancho‐Balsells, A., Fernández, J., Soto, D., Puigdellívol, M., Gasull, X., Alberch, J., et al. (2023) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2023.01.016 · Cited by 36
Genetic Interactions Explain Variance in Cingulate Amyloid Burden: An AV-45 PET Genome-Wide Association and Interaction Study in the ADNI Cohort
Li, J., Zhang, Q., Chen, F., Yan, J., Kim, S., Wang, L., Feng, W., Saykin, A. J., Liang, H., & Shen, L. (2015) · BioMed Research International · doi:10.1155/2015/647389 · Cited by 34
Epistatic Genetic Effects among Alzheimer’s Candidate Genes
Hohman, T. J., Koran, M. E. I., Thornton‐Wells, T. A., & Initiative, A. D. N. (2013) · PLoS ONE · doi:10.1371/journal.pone.0080839 · Cited by 35
Serum cholesterol and variant in cholesterol-related gene CETP predict white matter microstructure
Warstadt, N. M., Dennis, E. L., Jahanshad, N., Omid Kohannim, A., Nir, T. M., McMahon, K. L., de Zubicaray, G. I., Montgomery, G. W., Henders, A. K., Martin, N. G., et al. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.05.024 · Cited by 34
Alzheimer's disease genetics: lessons to improve disease modelling
Guerreiro, R. J., & Hardy, J. (2011) · Biochemical Society Transactions · doi:10.1042/bst0390910 · Cited by 33
Biomarkers of Alzheimer’s Disease Risk in Peripheral Tissues; Focus on Buccal Cells
François, M., Leifert, W. R., Martins, R. N., Thomas, P., & Fenech, M. F. (2014) · Current Alzheimer Research · doi:10.2174/1567205011666140618103827 · Cited by 34
Opportunities in pharmacogenomics for the treatment of Alzheimer’s disease
Cacabelos, R., Torrellas, C., & Carrera, I. (2015) · Future Neurology · doi:10.2217/fnl.15.12 · Cited by 32
GSK-3/CREB pathway involved in the gx-50's effect on Alzheimer's disease
Tang, M., Shi, S., Guo, Y., Xu, W., Wang, L., Chen, Y., Wang, Z., & Qiao, Z. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.02.008 · Cited by 32
Motor hyperactivation during cognitive tasks: An endophenotype of juvenile myoclonic epilepsy
Caciagli, L., Wandschneider, B., Centeno, M., Vollmar, C., Vos, S. B., Trimmel, K., Long, L., Xiao, F., Lowe, A. J., Sidhu, M. K., et al. (2020) · Epilepsia · doi:10.1111/epi.16575 · Cited by 30
Promising Genetic Biomarkers of Preclinical Alzheimer's Disease: The Influence ofAPOEandTOMM40on Brain Integrity
Ferencz, B., Karlsson, S., & Kalpouzos, G. (2012) · International Journal of Alzheimer s Disease · doi:10.1155/2012/421452 · Cited by 35
The effects of PPARγ on the regulation of the TOMM40 - APOE - C1 genes cluster
Subramanian, S., Gottschalk, W. K., Kim, S. Y., Roses, A. D., & Chiba‐Falek, O. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2017.01.004 · Cited by 33
CETP polymorphisms associate with brain structure, atrophy rate, and Alzheimer’s disease risk in an APOE-dependent manner
Initiative, A. D. N., Murphy, E. A., Roddey, J. C., McEvoy, L. K., Holland, D., Hagler, D. J., Dale, A. M., & Brewer, J. B. (2011) · Brain Imaging and Behavior · doi:10.1007/s11682-011-9137-0 · Cited by 32
On the Etiopathogenesis and Pathophysiology of Alzheimer’s Disease: A Comprehensive Theoretical Review
Tobore, T. O. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-181052 · Cited by 32
Association of β-Amyloid, Microglial Activation, Cortical Thickness, and Metabolism in Older Adults Without Dementia
Cai, Y. Q., Shi, D., Lan, G., Chen, L., Jiang, Y., Zhou, L., Guo, T., & Initiative, A. D. N. (2024) · Neurology · doi:10.1212/wnl.0000000000209205 · Cited by 31
Increased CNV-Region deletions in mild cognitive impairment (MCI) and Alzheimer's disease (AD) subjects in the ADNI sample
Guffanti, G., Torri, F., Rasmussen, J. M., Clark, A. P., Lakatos, A., Turner, J. A., Fallon, J. H., Saykin, A. J., Weiner, M. W., Vawter, M. P., et al. (2013) · Genomics · doi:10.1016/j.ygeno.2013.04.004 · Cited by 31
TOMM40 in Cerebral Amyloid Angiopathy Related Intracerebral Hemorrhage: Comparative Genetic Analysis with Alzheimer’s Disease
(ADNI), T. A. D. N. I., Valant, V., Keenan, B. T., Anderson, C. D., Shulman, J. M., Devan, W. J., Ayres, A. M., Schwab, K. M., Goldstein, J. N., Viswanathan, A., et al. (2012) · Translational Stroke Research · doi:10.1007/s12975-012-0161-1 · Cited by 30
Mitochondrial Haplotypes Associated with Biomarkers for Alzheimer’s Disease
Ridge, P. G., Koop, A., Maxwell, T. J., Bailey, M. H., Swerdlow, R. H., Kauwe, J. S. K., Honea, R. A., & Initiative, A. D. N. (2013) · PLoS ONE · doi:10.1371/journal.pone.0074158 · Cited by 30
Relationship Between Genetic Risk Factors and Markers for Alzheimer’s Disease Pathology
Elias-Sonnenschein, L. S., Bertram, L., & Visser, P. J. (2012) · Biomarkers in Medicine · doi:10.2217/bmm.12.56 · Cited by 28
Functional plasticity of the BNIP‐2 and Cdc42GAP Homology (BCH) domain in cell signaling and cell dynamics
Pan, C. Q., & Low, B. C. (2012) · FEBS Letters · doi:10.1016/j.febslet.2012.04.023 · Cited by 29
Genetic pathway‐based hierarchical clustering analysis of older adults with cognitive complaints and amnestic mild cognitive impairment using clinical and neuroimaging phenotypes
Sloan, C., Shen, L., West, J. D., Wishart, H. A., Flashman, L. A., Rabin, L. A., Santulli, R. B., Guerin, S. J., Rhodes, C. H., Tsongalis, G. J., et al. (2010) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.31078 · Cited by 28
The TOMM40 poly-T rs10524523 variant is associated with cognitive performance among non-demented elderly with type 2 diabetes
Greenbaum, L., Ravona‐Springer, R., Lutz, M. W., Heymann, A. D., Lubitz, I., Cooper, I., Kravitz, E., Sano, M. C., Roses, A. D., Silverman, J. M., et al. (2014) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2014.06.002 · Cited by 27
Interactions between GSK3β and amyloid genes explain variance in amyloid burden
Hohman, T. J., Koran, M. E. I., & Thornton‐Wells, T. A. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.08.032 · Cited by 28
Hippocampal thinning linked to longer TOMM40 poly‐T variant lengths in the absence of the APOE ε4 variant
Burggren, A. C., Mahmood, Z., Harrison, T. M., Siddarth, P., Miller, K. J., Small, G. W., Merrill, D. A., & Bookheimer, S. Y. (2017) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2016.12.009 · Cited by 27
TOMM40 rs2075650 May Represent a New Candidate Gene for Vulnerability to Major Depressive Disorder
McFarquhar, M., Elliott, R., McKie, S., Thomas, E., Downey, D., Mekli, K., Toth, Z. G., Anderson, I. M., Deakin, J. F. W., & Juhász, G. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.22 · Cited by 27
Profound Impact of Decline in N-Acetylgalactosamine-4-Sulfatase (Arylsulfatase B) on Molecular Pathophysiology and Human Diseases
Tobacman, J. K., & Bhattacharyya, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232113146 · Cited by 25
Identification of potentially functional modules and diagnostic genes related to amyotrophic lateral sclerosis based on the WGCNA and LASSO algorithms
Daneshafrooz, N., Cham, M. B., Majidi, M., & Panahi, B. (2022) · Scientific Reports · doi:10.1038/s41598-022-24306-2 · Cited by 25
Genetic architecture of resilience of executive functioning
Initiative, A. D. N., Mukherjee, S., Kim, S., Gibbons, L. E., Nho, K. T., Risacher, S. L., Glymour, M. M., Habeck, C. G., Lee, G. J., Mormino, E. C., et al. (2012) · Brain Imaging and Behavior · doi:10.1007/s11682-012-9184-1 · Cited by 25
Boosting power to detect genetic associations in imaging using multi-locus, genome-wide scans and ridge regression
Omid Kohannim, A., Hibar, D. P., Stein, J. L., Jahanshad, N., Jack, C. R., Weiner, M. W., Toga, A. W., & Thompson, P. M. (2011) · IEEE International Symposium on Biomedical Imaging (ISBI) · doi:10.1109/isbi.2011.5872769 · Cited by 24
A Genome-Wide Association Study Suggests Novel Loci Associated with a Schizophrenia-Related Brain-Based Phenotype
Haß, J., Walton, E., Kirsten, H., Liu, J., Priebe, L., Wolf, C., Mirza‐Schreiber, N., Gollub, R. L., White, T. J. H., Roessner, V., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0064872 · Cited by 25
Genes associated with anhedonia: a new analysis in a large clinical trial (GENDEP)
Ren, H., Fabbri, C., Uher, R., Rietschel, M., Mors, O. N., Henigsberg, N., Hauser, J., Zobel, A. W., Maier, W., Dernovšek, M. Z., et al. (2018) · Translational Psychiatry · doi:10.1038/s41398-018-0198-3 · Cited by 23
Genome-wide association study of hippocampal atrophy rate in non-demented elders
Guo, Y., Initiative, O. B. O. A. D. N., Xu, W., Li, J.-Q., Ou, Y.-N., Shen, X.-N., Huang, Y.-Y., Dong, Q., Tan, L., & Yu, J.-T. (2019) · Aging · doi:10.18632/aging.102470 · Cited by 20
Multilocus genetic profiling to empower drug trials and predict brain atrophy
Omid Kohannim, A., Hua, X., Rajagopalan, P., Hibar, D. P., Jahanshad, N., Grill, J. D., Apostolova, L. G., Toga, A. W., Jack, C. R., Weiner, M. W., et al. (2013) · NeuroImage Clinical · doi:10.1016/j.nicl.2013.05.007 · Cited by 24
Gene Expression Profiling of Tuberculous Meningitis Co-infected with HIV
Kumar, G. S. S. (2012) · Journal of Proteomics & Bioinformatics · doi:10.4172/jpb.1000243 · Cited by 25
Identifying differential regulatory control of APOE ɛ4 on African versus European haplotypes as potential therapeutic targets
Nuytemans, K., Vasquez, M. L., Wang, L., Booven, D. V., Griswold, A. J., Rajabli, F., Celis, K., Oron, O., Hofmann, N. K., Rolati, S., et al. (2022) · Alzheimer s & Dementia · doi:10.1002/alz.12534 · Cited by 22
Elucidating novel dysfunctional pathways in Alzheimer's disease by integrating loci identified in genetic and epigenetic studies
Smith, A. R., Mill, J. S., Smith, R. G., & Lunnon, K. (2016) · Neuroepigenetics · doi:10.1016/j.nepig.2016.05.001 · Cited by 21
Genome-wide association study of subcortical brain volume in PTSD cases and trauma-exposed controls
Morey, R. A., Davis, S. L., Garrett, M. E., Haswell, C. C., Workgroup, M.-A. M., Marx, C. E., Beckham, J. C., McCarthy, G., Hauser, M. A., & Ashley‐Koch, A. E. (2017) · Translational Psychiatry · doi:10.1038/s41398-017-0021-6 · Cited by 21
Willin/FRMD6: A Multi-Functional Neuronal Protein Associated with Alzheimer’s Disease
Chen, D., Yu, W., Aitken, L., & Gunn‐Moore, F. J. (2021) · Cells · doi:10.3390/cells10113024 · Cited by 21
Fine mapping of the chromosome 10q11-q21 linkage region in Alzheimer's disease cases and controls
Fallin, M. D., Szymanski, M., Wang, R., Gherman, A., Bassett, S. S., & Avramopoulos, D. (2010) · Neurogenetics · doi:10.1007/s10048-010-0234-9 · Cited by 21
Genes, Brains, and Behavior: Imaging Genetics for Neuropsychiatric Disorders
Arslan, A. (2015) · Journal of Neuropsychiatry · doi:10.1176/appi.neuropsych.13080185 · Cited by 25
Probing the role of PPARγ in the regulation of late-onset Alzheimer’s disease-associated genes
Barrera, J., Subramanian, S., & Chiba-Falek, O. (2018) · PLOS ONE · doi:10.1371/journal.pone.0196943 · Cited by 21
Imaging genetics — towards discovery neuroscience
Ge, T., Schumann, G., & Feng, J. (2013) · Quantitative Biology · doi:10.1007/s40484-013-0023-1 · Cited by 21
Faster progression from MCI to probable AD for carriers of a single-nucleotide polymorphism associated with type 2 diabetes
Girard, H., Potvin, O., Nugent, S., Dallaire‐Théroux, C., Cunnane, S. C., & Duchesne, S. (2017) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2017.11.013 · Cited by 20
A telescope GWAS analysis strategy, based on SNPs-genes-pathways ensamble and on multivariate algorithms, to characterize late onset Alzheimer’s disease
Squillario, M., Abate, G., Tomasi, F., Tozzo, V., Barla, A., Uberti, D. L., Initiative, T. A. D. N., Weiner, M. W., Aisen, P. S. S., Petersen, R. C., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-67699-8 · Cited by 20
The association between TOMM40 gene polymorphism and spontaneous brain activity in amnestic mild cognitive impairment
Liu, X., Bai, F., Yue, C., Shi, Y., Yu, H., Luo, B., & Zhang, Z. (2014) · Journal of Neurology · doi:10.1007/s00415-014-7368-x · Cited by 20
APOE, TOMM40, and sex interactions on neural network connectivity
Li, T., Pappas, C. A., Le, S. T., Wang, Q., Klinedinst, B. S., Larsen, B. A., Pollpeter, A., Lee, L. Y., Lutz, M. W., Gottschalk, W. K., et al. (2021) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2021.09.020 · Cited by 19

Authors: Potkin, S. G., Guffanti, G., Lakatos, A., Turner, J. A., Kruggel, F., Fallon, J. H., Saykin, A. J., Orro, A., Lupoli, S., Salvi, E., Weiner, M., Macciardi, F., & Initiative, F. T. A. D. N.
Affiliations: University of California, Irvine (US)
University of Milan (IT)
Indiana University Indianapolis (US)
Institute of Biomedical Technologies (IT)
Vita-Salute San Raffaele University (IT)
University of California, San Francisco (US)
Corresponding author: Potkin, Steven G.
ORCID: Potkin, Steven G.
Lakatos, Anita
Turner, Jessica A.
Kruggel, Frithjof
Saykin, Andrew J.
Orro, Alessandro
Salvi, Erika
Weiner, Michael
Macciardi, Fabio
Venue: PLoS ONE
Publisher: Public Library of Science (PLoS)
Published: 2009-08-07
Volume: 4
Issue: 8
Pages: e6501
ISSN: 1932-6203 (ISSN-L)
DOI: 10.1371/journal.pone.0006501
PMC: PMC2719581
OpenAlex: W2162988145
Cited by: 376
References: 71
Citations by year: 2026: 2 · 2025: 8 · 2024: 15 · 2023: 17 · 2022: 15 · 2021: 6 · 2020: 22 · 2019: 14 · 2018: 21 · 2017: 25 · 2016: 21 · 2015: 27 · 2014: 28 · 2013: 36 · 2012: 36
FWCI: 25.99
Type: journal article
Language: en
Open access: gold
doi.org
Licence: cc-by
creativecommons.org/licenses/by/4.0/ (unspecified)
Locations: PLoS ONE (publishedVersion, cc-by)
PubMed Central (publishedVersion, cc-by)
PubMed (publishedVersion)
Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano) (submittedVersion, other-oa)
DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
eScholarship (California Digital Library) (submittedVersion, cc-by)
Figshare (submittedVersion, cc-by)
IUScholarWorks (Indiana University) (submittedVersion, cc-by)
Funders: Foundation for the National Institutes of Health (U01AG024904, AG024904)
Alzheimer's Association (U01 AG024904)
Bristol-Myers Squibb (U01 AG024904, AG024904)
Eli Lilly and Company (U01 AG024904, AG024904)
Pfizer (AG024904, U01 AG024904)
AstraZeneca
GlaxoSmithKline
Alzheimer's Disease Neuroimaging Initiative (3U01AG024904-03S5, ADNI U01 AG024904-01, U01AG024904, AG024904)
Novartis Pharmaceuticals Corporation (U01 AG024904, AG024904)
Northern California Institute for Research and Education (U01 AG024904)
Vanda Pharmaceuticals
Elan (U01 AG024904)
Eisai (U01 AG024904, AG024904)
National Institutes of Health (3u01ag024904-03s5, U01-AG024904, AG024904, ADNI U01 AG024904)
U.S. Food and Drug Administration
University of California, Los Angeles
University of California, San Diego
National Institute on Alcohol Abuse and Alcoholism
National Institute on Aging (U01-AG-024904, U01 AG024904-01, AG 024904, 3U01AG024904-03S5, U19AG010483, U24AG021886, 3U01AG024904)
National Institute of Biomedical Imaging and Bioengineering (U01 AG024904, AG024904)
National Center for Research Resources (U24RR021992, FBIRN U24-RR021992, RR021992, P20RR020837, TIGC-P20 RR020837-01, U01 AG024904)
Topics: Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
Keywords: Alzheimer's disease, hippocampal atrophy, genetic susceptibility, genome-wide association study, quantitative traits, apolipoprotein E, TOMM40, ephrin-A5, CAND1, MAGI2, arsB, single nucleotide polymorphisms, MRI phenotypes, sporadic Alzheimer's disease, ADNI
MeSH terms: Adult, Alzheimer Disease, Female, Hippocampus, Humans, Magnetic Resonance Imaging, Male, Case-Control Studies, Genetic Predisposition to Disease, Polymorphism, Single Nucleotide, Quantitative Trait Loci, Genome-Wide Association Study

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Hippocampal Atrophy as a Quantitative Trait in a Genome-Wide Association Study Identifying Novel Susceptibility Genes for Alzheimer's Disease

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks